vaccines • surveillance • healthcare-associated infections • public health • epidemiology
My research focuses on understanding what can be done to prevent infections: from the hospital to the community. I aim to understand how to better prevent infections in our most vulnerable populations (neonates, patients with underlying conditions such as children with cystic fibrosis). Following the implementation of quality improvement measures and interventions, I evaluate the impact of these various measures.
Boikos C, De Serres G, Lands LC, Boucher FD, Tapiéro B, Daigneault P, Quach C*. Safety of Live-Attenuated Influenza Vaccination in a Paediatric Population with Cystic Fibrosis. Pediatrics 2014; 134: e983-91. PMID: 25225145.
Blanchard AC, Quach C, Autmizguine J. Staphylococcal infections in infants: Updates and current challenges. Clinics in Perinatology 2015; 42:119-32. PMID: 25678000.
Quach C*, Milstone AM, Perpete C, Bonenfant M, Moore DL, Perreault T. Chlorh exidine Bathing in a Tertiary-Care Neonatal Intensive Care Unit: Impact on Central Line Associated Bloodstream Infections. Infect Control Hospit Epidemiol 2014; 35: 158-63. PMID: 24442078.
Gonzales M, Rocher I, Fortin E, Fontela PS, Kaouache M, Tremblay C, Frenette C, Quach C*. A Survey of Preventive Measures Used and their Effectiveness in Reducing Central Line-Associated Bloodstream Infections (CLABSI) in Intensive Care Units - A Regional Surveillance Program (SPIN-BACC). BMC Inf Dis 2013; 13: 562 - DOI: 10.1186/1471-2334-13-562.
Quach C*. Vaccinating High-Risk Children with the Intranasal Live-Attenuated Influenza Vaccine: the Quebec Experience. Paediatric Respiratory Reviews 2014; 15: 340-347. PMID: 25242731.